Prices delayed by at least 15 minutes | Print
Chemours Company (The) (CC)
Common StockThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Address
1007 Market Street
Wilmington
DE
USA
19899
Telephone
+1.302 7732263
Forecast key dates
Name | Key Date |
---|---|
The Chemours Co First Quarter Earnings Results for 2025 | 2025-04-30T00:00:00 |
The Chemours Co Fourth Quarter Earnings Conference Call for 2024 | 2025-03-28T08:00:00 |
The Chemours Co Fourth Quarter Earnings Results for 2024 | 2025-03-28T00:00:00 |
The Chemours Co Annual Report for 2024 | 2025-03-27T00:00:00 |
The Chemours Co Third Quarter Earnings Conference Call for 2024 | 2024-10-25T08:00:00 |
The Chemours Co Third Quarter Earnings Results for 2024 | 2024-10-25T00:00:00 |
The Chemours Co Second Quarter Earnings Conference Call for 2024 | 2024-07-26T08:00:00 |
The Chemours Co Second Quarter Earnings Results for 2024 | 2024-07-26T00:00:00 |
The Chemours Co First Quarter Earnings Conference Call for 2024 | 2024-05-01T08:00:00 |
The Chemours Co First Quarter Earnings Results for 2024 | 2024-04-30T00:00:00 |
The Chemours Co Annual General Meeting for 2024 | 2024-04-26T10:00:00 |
Previous key dates
Name | Key Date |
---|---|
The Chemours Co First Quarter Earnings Results for 2024 | 2024-04-30T00:00:00 |
The Chemours Co Annual General Meeting for 2024 | 2024-04-26T10:00:00 |
The Chemours Co Fourth Quarter Earnings Conference Call for 2023 | 2024-03-28T08:00:00 |
The Chemours Co Fourth Quarter Earnings Result for 2023 | 2024-03-28T00:00:00 |
The Chemours Co Annual Report for 2023 | 2024-03-27T00:00:00 |
the 2024 Oppenheimer Healthcare MedTech & Services Conference | 2024-03-13T00:00:00 |
The Chemours Co Third Quarter Earnings Conference Call for 2023 | 2023-10-27T08:00:00 |
The Chemours Co Third Quarter Earnings Result for 2023 | 2023-10-27T00:00:00 |
The Chemours Co Second Quarter Earnings Conference Call for 2023 | 2023-07-28T08:00:00 |
The Chemours Co Second Quarter Earnings Results for 2023 | 2023-07-27T00:00:00 |
The Chemours Co First Quarter Earnings Conference Call for 2023 | 2023-04-28T08:00:00 |
The Chemours Co First Quarter Earnings Result for 2023 | 2023-04-28T00:00:00 |
The Chemours Co Annual General Meeting for 2023 | 2023-04-26T10:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.